1. Sweiss NJ, Lower EE, Mirsaeidi M, Dudek S, Garcia JG, Perkins D, Finn PW, Baughman RP (2014) Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Resp J 43:1525–1528
2. American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. American journal of respiratory and critical care medicine 160:736–755
3. Baughman RP, Lower EE (2015) Clinical reviews in allergy & immunology. Treat Sarcoidosis 49:79–92
4. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr., Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, A Case Control Etiologic Study of Sarcoidosis (ACESS) Research Group (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889
5. Berrios I, Jun-O’Connell A, Ghiran S, Ionete C (2015) A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature. BMJ Case Rep : doi:10.1136/bcr-2014-208188